GapCO2 and Respiratory Rate in Patients Under Volume Mechanical Ventilation

NCT ID: NCT02867943

Last Updated: 2016-08-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

28 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-10-31

Study Completion Date

2016-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

As an approximate of the difference between venous-to-arterial CO2 tension (∆PCO2), ∆PCO2 is proportional to CO2 production and inversely related to cardiac output (Fick equation). Anaerobic CO2 production is thought to occur when tissue hypoxia is present, mostly because of buffering of bicarbonate ions by the protons produced in excess secondary to the hydrolysis of adenosine triphosphate. Therefore ∆PCO2 has been proposed as a marker of tissue hypoxia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

An increased ∆PCO2 (\> 6 mmHg) could be used to identify patients who still remain inadequately resuscitated, when deciding when to continue resuscitation despite a central venous oxygen saturation (ScvO2) \> 70% associated with elevated blood lactate levels.

Under steady states of both VO2 and VCO2, P (v-a) CO2 was observed to increase in parallel with the reduction in cardiac output. However, spontaneous breathing and hyperventilation may reduce PaCO2 and prevent the CO2 stagnation-induced rise in PvCO2.

To date,these studies of ∆PCO2 and respiratory rate in septic shock patients Under Volume Mechanical Ventilation are rarely.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Shock

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

respiratory rate is 10 breaths/min

GapCO2=Pv-aCO2 = PvCO2 - PaCO2;

Effects of venous-to-arterial CO2 tension difference after increased respiratory rate.

Effects of respiratory rate on gapCO2

Intervention Type OTHER

respiratory rate was started at 10 breaths/min and added by 2 breaths/min every 60 min up to 16 breaths/min

respiratory rate is 12 breaths/min

GapCO2=Pv-aCO2 = PvCO2 - PaCO2;

Effects of venous-to-arterial CO2 tension difference after increased respiratory rate.

Effects of respiratory rate on gapCO2

Intervention Type OTHER

respiratory rate was started at 10 breaths/min and added by 2 breaths/min every 60 min up to 16 breaths/min

respiratory rate is 14 breaths/min

GapCO2=Pv-aCO2 = PvCO2 - PaCO2;

Effects of venous-to-arterial CO2 tension difference after increased respiratory rate.

Effects of respiratory rate on gapCO2

Intervention Type OTHER

respiratory rate was started at 10 breaths/min and added by 2 breaths/min every 60 min up to 16 breaths/min

respiratory rate is 16 breaths/min

GapCO2=Pv-aCO2 = PvCO2 - PaCO2;

Effects of venous-to-arterial CO2 tension difference after increased respiratory rate.

Effects of respiratory rate on gapCO2

Intervention Type OTHER

respiratory rate was started at 10 breaths/min and added by 2 breaths/min every 60 min up to 16 breaths/min

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Effects of respiratory rate on gapCO2

respiratory rate was started at 10 breaths/min and added by 2 breaths/min every 60 min up to 16 breaths/min

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Patients were included in the study, if the attending physician find the persistence of signs of hypoperfusion (oliguria, mottled skin, central venous oxygen saturation (ScvO2) \<70 % despite a hemoglobin \> 8 g/dl),despite achieving adequate intravascular volume and adequate mean arterial pressure (MAP) \> 65 mmHg as recommended by the Surviving Sepsis Campaign.
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

105 Hospital of Chinese People's Liberation Army

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PLA-105-ICU

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.